N末端脑钠肽前体与心肌肌钙蛋白Ⅰ评价新生儿呼吸窘迫综合征预后的临床价值

doi:10.11852/zgetbjzz2019-0641

摘要/Abstract

摘要： 目的探讨N末端脑钠肽前体(NT-proBNP)与心肌肌钙蛋白Ⅰ(cTnⅠ)评价新生儿呼吸窘迫综合征(NRDS)预后的临床价值,为临床医师提供参考。方法选取2015年4月-2018年4月榆林市第一医院收治的110例NRDS患儿为病例组,同期选择本院60例非NRDS新生儿为对照组;并将NRDS患儿预后情况分为存活组与死亡组,比较各组一般临床资料的差异。同时采用Logistic回归方程分析NT-proBNP和cTnⅠ与NRDS患儿死亡的关系;采用ROC曲线评估两者预测NRDS发生的价值。结果病例组血浆NT-proBNP和cTnⅠ显著高于对照组,差异有统计学意义(t=24.329、51.075,P<0.05)。与存活组比较,死亡组出生时体重、氧合指数(PaO₂/FiO₂)水平较低,肌酸激酶(CK)、肌酸激酶同工酶(CK-MB)较高,差异有统计学意义(P<0.05);死亡组血浆NT-proBNP和cTnⅠ高于存活组,差异有统计学意义(P<0.05)。Ⅳ级NRDS患儿NT-proBNP和cTnⅠ水平高于Ⅰ级～Ⅲ级,Ⅲ级高于Ⅱ级和Ⅰ级,差异有统计学意义(P<0.05)。Spearman秩相关分析提示NT-proBNP和cTnI分别与NRDS严重程度分级呈正相关(r=0.329、0.287,P<0.05)。多元Logistic回归方程提示NT-proBNP(OR=3.115,95%CI:2.249~7.184)和cTnⅠ(OR=2.376,95%CI:1.582~6.110)是NRDS患儿死亡的危险因素(P<0.05)。NT-proBNP和cTnⅠ预测NRDS患儿死亡的ROC曲线下面积分别为0.769和0.691,两组联合预测的ROC曲线下面积显著高于两者单独预测面积,差异具有统计学意义(Z=2.854,P<0.05)。结论 NT-proBNP和cTnⅠ水平与NRDS患儿病情严重程度呈正相关,可能是此类患儿死亡的危险因素,两者联合检测在预测患儿预后方面具有较高的临床价值。

关键词: N末端脑钠肽前体, 肌钙蛋白Ⅰ, 新生儿呼吸窘迫综合征

Abstract: Objective To explore the clinical value of N-terminal pro-brain natriuretic peptide (NT-proBNP) and cardiac troponin Ⅰ(cTnⅠ) in evaluating the prognosis of neonatal respiratory distress syndrome (NRDS),in order to provide reference for clinical practice. Methods Totally 110 children with NRDS hospitalized in Yulin First Hospital from April 2015 to April 2018 were enrolled in this study as the case group,and 60 infants without NRDS in the meantime were selected as control.Children with NRDS were divided into survival group and death group according to the prognosis.Differences on general clinical data among each group were compared.Logistic regression equation was used to analyze the relationship between the death of NRDS children and the levels of NT-proBNP and cTnⅠ.And ROC curve was used to evaluate the predictive value of NRDS. Results Plasma levels of NT-proBNP and cTnⅠ in case group were significantly higher than those in control group(t=24.329,51.075,P＜0.05).Compared with survival group,birth weight,oxygen index (PaO₂/FiO₂) were lower and the levels of creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) were significantly higher in the death group(P＜0.05).Plasma levels of NT-proBNP and cTnⅠ in death group were significantly higher than those in survival group (P<0.05).NT-proBNP and cTnⅠ levels in children with grade Ⅳ NRDS were significantly higher than those in children with grade Ⅰ-Ⅲ NRDS,so was in grade Ⅲ NRDS than those in grade Ⅰ-Ⅱ NRDS (P<0.05).Spearman rank correlation analysis indicated that the levels of NT-proBNP and cTnⅠ were positively correlated with NRDS severity respectively (r=0.329,0.287,P<0.05).Multiple Logistic regression equation suggested that NT-proBNP (OR=3.115,95%CI:2.249-7.184) and cTnⅠ(OR=2.376,95%CI:1.582-6.110) were risk factors of death (P<0.05).The area under ROC curve of NT-proBNP and cTnⅠ in predicting death of NRDS children was 0.769 and 0.691,respectively.The area under the ROC curve predicted by the two groups was significantly higher than that predicted by the two groups alone (Z=2.854,P<0.05). Conclusions The levels of NT-proBNP and cTnⅠ are positively correlated with the severity of NRDS,which may be risk factors for the death of NRDS children.Moreover,the combined detection of NT-proBNP and cTnⅠ levels has a high clinical value in predicting the prognosis.

Key words: N-terminalpro-brainnatriureticpeptide, cardiactroponinⅠ, neonatalrespiratorydistresssyndrome

中图分类号:

R722.1

吴婷婷, 贺巧峰, 曹玲. N末端脑钠肽前体与心肌肌钙蛋白Ⅰ评价新生儿呼吸窘迫综合征预后的临床价值[J]. 中国儿童保健杂志, 2019, 27(11): 1223-1227.

WU Ting-ting, HE Qiao-feng, CAO Ling. Clinical value of N-terminal pro-brain natriuretic peptide and cardiac troponin Ⅰ in evaluatingthe prognosis of neonatal respiratory distress syndrome[J]. journal1, 2019, 27(11): 1223-1227.

参考文献

[1] 章伟,陈波,张惠荣,等.SNAPPE-Ⅱ评分对新生儿呼吸窘迫综合征预后的预测价值[J].广东医学,2017,38(20):3153-3154.
[2] Delorme P,Goffinet F,Ancel PY,et al.Cause of preterm birth as a prognostic factor for mortality[J].Obstet Gynecol,2016,127 (1):40-48.
[3] 陈波,张惠荣,段为浩,等.两种危重评分对新生儿呼吸窘迫综合征患儿死亡风险的预测价值[J].中国现代医学杂志,2017,27(3):97-100.
[4] 胡亚美,江载芳.诸福棠实用儿科学[M].北京:人民卫生出版社,2002.
[5] Flori H,Dahmer MK,Sapru A,et al.Comorbidities and assessment of severity of pediatric acute respiratory distress syndrome:proceedings from the pediatric acute lung injury consensus conference[J].Pediatr Crit Care Med,2015,16(5 Suppl 1):41-50.
[6] Christopher MP,Wambach JA.Prevention and treatment of respiratory distress syndrome in preterm neonates[J].Neonatal Network,2018,37(3):169-177.
[7] 廖亮荣.机械通气与经鼻塞持续正压通气联合肺表面活性物质治疗新生儿呼吸窘迫综合征的疗效分析[J].中国妇幼保健,2018,33(2):432-434.
[8] NT-proBNP临床应用中国专家共识小组.NT-proBNP临床应用中国专家共识[J].中国心血管病研究,2011,9(6):401-408.
[9] Mishra RK,Judson G,Christenson RH,et al.The association of five-year changes in the levels of N-terminal fragment of the prohormone brain-Type natriuretic peptide (NT-proBNP) with subsequent heart failure and death in patients with stable coronary artery disease:the heart and soul study[J].Cardiology,2017,137(4):201-206.
[10] 侯彰华,彭华保,车玲,等.N端脑钠肽前体及Tei指数对新生儿缺氧性肺动脉高压右心室功能评价的意义[J].中国新生儿科杂志,2015,30(1):21-25.
[11] Zhu R,Nie Z.A clinical study of the N-Terminal pro-brain natriuretic peptide in myocardial injury after neonatal asphyxia [J].Pediatr Neonatol,2016,57(2):133-139.
[12] 尹同进,雍其军,成胜,等.围生期新生儿肺内源性与外源性急性呼吸窘迫综合征的呼吸力学指标及肺动脉压力变化[J].中华妇幼临床医学杂志:电子版,2018,14(5):571-577.
[13] 黄锂新,张若松,竺胜伟.西地那非治疗新生儿呼吸窘迫综合征并发持续肺动脉高压脑利钠肽的变化及意义[J].儿科药学杂志,2014,20(12):1-4.
[14] Chen CA.Diagnostic role of b-T type natriuretic peptide in clinical myocardial injury related to neonatal asphyxia[J].Pediatr Neonatol,2016,57(2):87-88.
[15] 冯琼.纳洛酮对新生儿呼吸窘迫综合征后氧化应激的影响及心肌损害的保护作用[J].临床肺科杂志,2016,21(8):1391-1394.
[16] 张成磊,黄勇翔,邸师红,等.高敏肌钙蛋白I、肌钙蛋白I联合心肌标志物对微小心肌损伤的早期诊断价值[J].检验医学与临床,2017,14(14):3355.
[17] 袁二伟,曲海新,张雅静,等.不同病情程度新生儿缺氧缺血性脑病患儿心肌酶谱和cTnⅠ水平的检测分析[J].川北医学院学报,2017,32(4):537-539.
[18] Lazzeri C,Bonizzoli M,Cozzolino M,et al.Serial measurements of troponin and echocardiography in patients with moderate-to-severe acute respiratory distress syndrome[J].J Crit Care,2016,33(6):132-136.
[19] Montaldo P,Rosso R,Chello G,et al.Cardiac troponin I concentrations as a marker of neurodevelopmental outcome at 18 months in newborns with perinatal asphyxia [J].J Perinatol,2014,34(4):292-295.